IGC Pharma, Inc. Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2010 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
IGC Pharma, Inc. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2010 to Q3 2024.
- IGC Pharma, Inc. Earnings Per Share, Diluted for the quarter ending September 30, 2024 was -0.02 USD/shares, a 60% increase year-over-year.
- IGC Pharma, Inc. annual Earnings Per Share, Diluted for 2016 was -0.07 USD/shares, a 58.8% increase from 2015.
- IGC Pharma, Inc. annual Earnings Per Share, Diluted for 2015 was -0.17 USD/shares, a 45.2% increase from 2014.
- IGC Pharma, Inc. annual Earnings Per Share, Diluted for 2014 was -0.31 USD/shares, a 16.2% increase from 2013.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)